search
Back to results

Real-time fMRI Neurofeedback in Patients With MCI

Primary Purpose

Mild Cognitive Impairment

Status
Recruiting
Phase
Not Applicable
Locations
Switzerland
Study Type
Interventional
Intervention
real-time fMRI based neurofeedback from the hippocampus
real-time fMRI based neurofeedback from another brain area
Sponsored by
University of Bern
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Mild Cognitive Impairment

Eligibility Criteria

60 Years - 80 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Intact activities of daily living
  • Fluent in German
  • Normal/corrected-to-normal vision
  • Written informed consent

Exclusion Criteria:

  • Dementia
  • Current/lifetime severe psychiatric or neurological disorder
  • History of seizures
  • Psychotropic medication
  • Currently/lifetime drug or alcohol abuse
  • Brain damage
  • Magnetisable implants

Sites / Locations

  • SITEM (Swiss Institute for Translational and Entrepreneurial Medicine)Recruiting
  • University of Zurich

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Active Comparator

Sham Comparator

Experimental

Sham Comparator

Arm Label

healthy elderly participants receiving feedback from the hippocampus

healthy elderly participants receiving feedback from another area

patients with MCI receiving feedback from the hippocampus

patients with MCI receiving feedback from another brain area

Arm Description

This group will consist of healthy elderly volunteers, who will receive feedback from their hippocampal activity.

This group will consist of healthy elderly volunteers, who will receive feedback from another brain area.

This group will consist of patients with mild cognitive impairment, who will receive feedback from their hippocampal activity.

This group will consist of patients with mild cognitive impairment, who will receive feedback from another brain area.

Outcomes

Primary Outcome Measures

Rate of change in hippocampal activity during a memory task
Measured by fMRI (rate of change in activity from baseline to after the intervention)

Secondary Outcome Measures

Rate of change in memory performance
Measured by fMRI (memory performance change from baseline to after the intervention)
Rate of change from in memory performance (behavioural)
Measured behaviourally (memory performance change from baseline to after the intervention)

Full Information

First Posted
July 4, 2019
Last Updated
May 9, 2023
Sponsor
University of Bern
Collaborators
University of Zurich
search

1. Study Identification

Unique Protocol Identification Number
NCT04020744
Brief Title
Real-time fMRI Neurofeedback in Patients With MCI
Official Title
Targeting Hippocampal Hyperactivity With Real-time Functional MRI Based Neurofeedback in Elderly Individuals With and Without Memory Problems
Study Type
Interventional

2. Study Status

Record Verification Date
May 2023
Overall Recruitment Status
Recruiting
Study Start Date
July 1, 2020 (Actual)
Primary Completion Date
September 30, 2023 (Anticipated)
Study Completion Date
December 31, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Bern
Collaborators
University of Zurich

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Increased activity in the hippocampus (i.e., hyperactivity) during a fMRI memory task was found in patients with Mild Cognitive Impairment due to Alzheimer's disease (MCI). Those with increased hippocampal activity exhibited elevated clinical progression. Reducing hippocampal hyperactivity with pharmacological treatment reduced hyperactivity and improved memory performance. The investigators of this study will test whether real-time fMRI neurofeedback will also downregulate hippocampal activity and thereby improve memory performance.
Detailed Description
Alzheimer's disease (AD) is an insidious and progressive neurodegenerative disorder accompanied by extracellular deposits of beta-amyloid ( aβ) and the increase of cognitive dysfunctions. Several functional magnet resonance imaging (fMRI) studies in the prodromal stage of AD (i.e., in MCI) have found increased hippocampal activity during a memory task to be predictive of memory worsening and disease progression. In this study the investigators are aiming to reduce hippocampal hyperactivity with real-time fMRI neurofeedback and test whether this will improve memory performance. This study will use a randomized, single-blind, parallel group design. Patients with MCI and healthy participants will be assigned to receive feedback from either the hippocampus (experimental group, N=42) or from another brain area (alternate ROI feedback group, N=42). All participants will be instructed to downregulate activity.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Mild Cognitive Impairment

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Masking Description
For blinding of the participants, they will be told that they will be asked to regulate one of two brain regions, without mentioning the specific area.
Allocation
Randomized
Enrollment
84 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
healthy elderly participants receiving feedback from the hippocampus
Arm Type
Active Comparator
Arm Description
This group will consist of healthy elderly volunteers, who will receive feedback from their hippocampal activity.
Arm Title
healthy elderly participants receiving feedback from another area
Arm Type
Sham Comparator
Arm Description
This group will consist of healthy elderly volunteers, who will receive feedback from another brain area.
Arm Title
patients with MCI receiving feedback from the hippocampus
Arm Type
Experimental
Arm Description
This group will consist of patients with mild cognitive impairment, who will receive feedback from their hippocampal activity.
Arm Title
patients with MCI receiving feedback from another brain area
Arm Type
Sham Comparator
Arm Description
This group will consist of patients with mild cognitive impairment, who will receive feedback from another brain area.
Intervention Type
Other
Intervention Name(s)
real-time fMRI based neurofeedback from the hippocampus
Intervention Description
During real-time fMRI neurofeedback, participants are trained to 'control' hippocampal activity. The training is accomplished by continuously measuring brain activity, analysing it in real-time, and then providing feedback about the current (and the targeted) brain activity to the participant.
Intervention Type
Other
Intervention Name(s)
real-time fMRI based neurofeedback from another brain area
Intervention Description
During real-time fMRI neurofeedback, participants are trained to 'control' hippocampal activity. The training is accomplished by continuously measuring brain activity, analysing it in real-time, and then providing feedback about the current (and the targeted) brain activity to the participant.
Primary Outcome Measure Information:
Title
Rate of change in hippocampal activity during a memory task
Description
Measured by fMRI (rate of change in activity from baseline to after the intervention)
Time Frame
Directly after the intervention
Secondary Outcome Measure Information:
Title
Rate of change in memory performance
Description
Measured by fMRI (memory performance change from baseline to after the intervention)
Time Frame
Directly after the intervention
Title
Rate of change from in memory performance (behavioural)
Description
Measured behaviourally (memory performance change from baseline to after the intervention)
Time Frame
Directly after the intervention
Other Pre-specified Outcome Measures:
Title
Strategies for Regulation of hippocampal activity
Description
Which strategies were particularly helpful in downregulation of hippocampal activity (number of times the strategies were mentioned)
Time Frame
Intervention
Title
Predictors of neurofeedback success
Description
Variables extracted from questionnaires that may predict who will respond to neurofeedback
Time Frame
Post-Intervention

10. Eligibility

Sex
All
Minimum Age & Unit of Time
60 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Intact activities of daily living Fluent in German Normal/corrected-to-normal vision Written informed consent Exclusion Criteria: Dementia Current/lifetime severe psychiatric or neurological disorder History of seizures Psychotropic medication Currently/lifetime drug or alcohol abuse Brain damage Magnetisable implants
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Jessica Peter, PD Dr.
Phone
+41 31 932 89 03
Email
jessica.peter@upd.unibe.ch
First Name & Middle Initial & Last Name or Official Title & Degree
Jessica Peter
Phone
+41 31 932 89 03
Email
jessica.peter@upd.unibe.ch
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jessica Peter, PD Dr.
Organizational Affiliation
University of Bern
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Stefan Klöppel, Prof. Dr.
Organizational Affiliation
University of Bern
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Frank Scharnowski, Prof. Dr.
Organizational Affiliation
University of Vienna
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Roland Wiest, Prof. Dr.
Organizational Affiliation
University of Bern
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Katharina Klink
Organizational Affiliation
University of Bern
Official's Role
Study Chair
Facility Information:
Facility Name
SITEM (Swiss Institute for Translational and Entrepreneurial Medicine)
City
Bern
ZIP/Postal Code
3010
Country
Switzerland
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jessica Peter, PD Dr.
Phone
+41319328903
Ext
+41319328903
Email
jessica.peter@upd.unibe.ch
First Name & Middle Initial & Last Name & Degree
Katharina Klink
Phone
+41319328827
Email
katharina.klink@upd.unibe.ch
Facility Name
University of Zurich
City
Zurich
ZIP/Postal Code
8092
Country
Switzerland
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Lars Michels, Dr.
Phone
+41 44 255 49 65
Email
lars.michels@usz.ch

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
33563242
Citation
Klink K, Jaun U, Federspiel A, Wunderlin M, Teunissen CE, Kiefer C, Wiest R, Scharnowski F, Sladky R, Haugg A, Hellrung L, Peter J. Targeting hippocampal hyperactivity with real-time fMRI neurofeedback: protocol of a single-blind randomized controlled trial in mild cognitive impairment. BMC Psychiatry. 2021 Feb 9;21(1):87. doi: 10.1186/s12888-021-03091-8.
Results Reference
derived

Learn more about this trial

Real-time fMRI Neurofeedback in Patients With MCI

We'll reach out to this number within 24 hrs